New England Capital Financial Advisors LLC
Position in JNJ — Johnson & Johnson
CIK 1964652
MERIDEN, CT
Position in JNJ
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$726,354
+$151,676 QoQ
Shares Held
2,860
+21.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
2.36%
of 13F equity value
Holder Rank
#1,424
of 2,126 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Capital Financial Advisors LLC holds $1,698,786 across 11 Drug Manufacturers - General names. JNJ ranks #1 (42.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
2,860 | $726,354 | |
| 2 | MRK |
Merck & Co., Inc.
|
2,193 | $281,800 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
4,319 | $248,860 | |
| 4 | PFE |
Pfizer Inc
|
5,713 | $137,569 | |
| 5 | AZN |
Astrazeneca PLC
|
560 | $106,187 | |
| 6 | ABBV |
AbbVie Inc.
|
363 | $91,345 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
390 | $49,272 | |
| 8 | LLY |
ELI LILLY & Co
|
34 | $40,780 |
All Filings in JNJ
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $726,354 | 2,860 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $574,678 | 2,351 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $484,676 | 2,342 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $432,399 | 2,332 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $348,422 | 2,281 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $395,362 | 2,384 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $358,802 | 2,481 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $406,932 | 2,511 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $367,446 | 2,514 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $395,316 | 2,499 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $472,100 | 3,012 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $466,627 | 2,996 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $538,767 | 3,255 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $513,825 | 3,315 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $582,238 | 3,296 | Shares | Sole | 2023-02-06 | |
| No filing history on record for this holder in this stock. | ||||||